PBI is committed to developing new treatments for blood cancers and facilitates patient participation in clinical trials to access potentially lifesaving treatments not currently available elsewhere. Your support will enable us to participate in testing new treatment options to improve the health outcomes for patients with blood disorders, including multiple myeloma.
PBI's Clinical Trials Unit actively runs numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers. We regularly take part in new clinical trials for improved treatments for blood disorders – this provides Western Australians with the opportunity to access new treatments.
PBI regularly participates in clinical trials to support improved treatments for blood disorders, providing Western Australians with the opportunity to access new treatments.